Public Health Agency of Canada

FOI page guess 404'd, not located this review

Current this library's internal records: Public Health Agency of Canada's 2026-27 Departmental Plan (2027)

Completeness

• Document shelf: 9 rows (9 archived · 0 staged · 0 pending · 0 missing)
• Backgrounder: on file
• Strategy-evolution brief: on file
• Custody audit: 9 of 9 row(s) audited, all clean
• Last verified: 2026-08-02 · this org has NOT had a full discovery-verification pass (our discovery-verification log)

Endpoints

• Website
• Open data
• API: checked — none found
• RSS: checked — none found
• Newsroom: checked — none found
• FOI / access requests: checked — none found

Document shelf (9 rows)

Backgrounder

Source: this library's internal records — a mechanical research draft, not independently reviewed for publication; reproduced as-is.

Public Health Agency of Canada - backgrounder

Backgrounder / 2026-07-30 / registry row: fed-public-health-agency-canada (this library's government-document registry) / lens file for this org's series briefs

Mandate & statutory basis

Established by the Public Health Agency of Canada Act, S.C. 2006, c. 5 (https://laws-lois.justice.gc.ca/eng/acts/P-29.5/index.html - link verified, title/citation confirmed, current to 2026-06-14). Section 3 establishes PHAC as a federal institution assisting the Minister of Health with public health powers and functions, including "health protection and promotion, population health assessment, health surveillance, disease and injury prevention, and public health emergency preparedness" (statute, full text at https://laws-lois.justice.gc.ca/eng/acts/P-29.5/FullText.html). PHAC's own stated mandate is to promote "the health and well-being of Canadians of all ages by conducting surveillance and public health research and supporting community-based projects" (2026-27 Departmental Plan, https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/reports-plans-priorities/2026-2027-departmental-plan.html, fetched via https://r.jina.ai/[same URL]).

Roles, responsibilities & scope

Organized around three core responsibilities in its 2026-27 planning: health promotion and chronic disease prevention, infectious disease prevention and control, and health security (2026-27 Departmental Plan, as above). Statutory functions include disease surveillance, population health assessment, and public health emergency preparedness and response (statute, s.3, FullText.html).

Governance & reporting line

Led by a President, appointed by the Governor in Council to hold office during pleasure for a renewable term of up to five years, serving as CEO with deputy-head status; a separately Governor-in-Council-appointed Chief Public Health Officer, required to be a qualified public health professional, acts as the lead health professional of the Government of Canada and provides science-based advice to the Minister and President (statute, FullText.html). The Chief Public Health Officer must submit an annual report on Canada's public health status to the Minister within six months of fiscal year-end, which the Minister tables in Parliament within the first 15 sitting days (statute, FullText.html). As of the 2026-27 Departmental Plan, the responsible minister is the Honourable Marjorie Michel, Minister of Health (2026-27 Departmental Plan, as above). Registry lists org_type as "agency" with no listed parent (registry row, registry id fed-public-health-agency-canada).

Budget scale

~$1.527B total planned spending for FY2026-27 (including internal services): health promotion and chronic disease prevention ~$341.2M, infectious disease prevention and control ~$744.8M, health security ~$257.0M; 2,854 planned FTEs (2026-27 Departmental Plan, https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/reports-plans-priorities/2026-2027-departmental-plan.html).

Institutional history

Created in 2004 by administrative/Order-in-Council action following the 2003 SARS outbreak, then placed on a full statutory footing in 2006 by the Public Health Agency of Canada Act (S.C. 2006, c. 5) (statute, https://laws-lois.justice.gc.ca/eng/acts/P-29.5/index.html); ⚠️ still being checked - the 2004 pre-statutory creation date/instrument is widely reported but was not independently confirmed against a primary Government of Canada source this review.

Strategy evolution brief

Source: this library's internal records — a mechanical research draft, not independently reviewed for publication; reproduced as-is.

Public Health Agency of Canada - strategy evolution

2026-08-02 / registry: fed-public-health-agency-canada / grounded in archived copies (cited document id + sha256) / read through our research file for that body

TL;DR: The archived series (9 docs, 4 Departmental Plans + 4 Departmental Results Reports + 1 short Auditor General report, spanning FY2021-22 through FY2026-27 in planning terms) shows a clean three-act arc: peak pandemic emergency response (FY2021-22, $8.7B actual spending) through active wind-down (FY2023-24, $4.4B) to normalized/endemic footing with structural budget cuts (FY2024-25, $1.5B) — an 82% spending decline in three years, driven almost entirely by the expiry of COVID-19 border, quarantine, vaccine-procurement, and surge-capacity authorities. The space vacated by COVID is filled by a consistent, recurring cluster: mental health/suicide prevention (9-8-8 helpline), opioids/substance use, measles and H5N1 avian-influenza resurgence, antimicrobial resistance, and domestic vaccine biomanufacturing (Moderna, later Laval mRNA facility). The most load-bearing numbers are the spending collapse itself ($8,705,432,497 in FY2021-22 to $1,534,914,270 actual in FY2024-25) and two separate, sequential, differently-named federal austerity exercises layered on top of that decline — Budget 2023's "Refocusing Government Spending" ($13.2M→$27.6M by 2026-27+, with 9%/16% workforce cuts in 2024-25) and Budget 2025's newer "Comprehensive Expenditure Review" ($12.7M→$88.8M by 2028-29, ~53 FTE reduction) — first disclosed in the 2026-27 Departmental Plan. One open question the archived series cannot resolve: whether the Comprehensive Expenditure Review's ~53-FTE reduction and the broader "Stabilization to Sustainability" funding-authority expiry described in dp-2027 represent a one-time post-pandemic reset or the start of a further multi-year contraction, since the series ends at the FY2026-27 planning horizon.

Backgrounder summary

PHAC is established by the Public Health Agency of Canada Act, S.C. 2006, c. 5, assisting the Minister of Health with "health protection and promotion, population health assessment, health surveillance, disease and injury prevention, and public health emergency preparedness" (backgrounder, citing statute s.3). It is led by a Governor-in-Council-appointed President (deputy-head status) and a separately appointed Chief Public Health Officer who reports annually to Parliament on Canada's public health status. The backgrounder's cited FY2026-27 budget scale (~$1.527B total planned spending, 2,854 planned FTEs, three core responsibilities: health promotion and chronic disease prevention ~$341.2M, infectious disease prevention and control ~$744.8M, health security ~$257.0M) is independently re-confirmed below against dp-2027's own Table 15 (fed-public-health-agency-canada-dp-2027, 24cc5bc1ac28: gross planned spending $1,528,373,768, net $1,527,423,768 — a recorded standing decision: this brief separately re-verifies rather than merely relaying the backgrounder figure). The backgrounder names the Honourable Marjorie Michel as Minister of Health as of the 2026-27 Departmental Plan; this series independently traces the full ministerial and presidential succession behind that endpoint (see Priority evolution). PHAC was created in 2004 administratively following the 2003 SARS outbreak, placed on statutory footing in 2006 (backgrounder; ⚠️ still being checked flag on the 2004 date/instrument carried forward from the backgrounder, not resolved by this series).

Series inventory

_index.json: 9 ok / 0 stub-suspected / 0 extract-failed.

All 9 documents were read for substantive content: drr-2024 and drr-2025 via a salvaged pre-digest (spot-verified against source text below, see Residuals & gaps), the remaining 7 via direct reads (2 by a parallel automated read, 5 directly in this review). No stub-suspected or failed-extraction documents in this org's set — the stub detector had nothing to disagree on either direction.

Priority evolution

FY2021-22 (drr-2022, 5f36bf45a086) — peak pandemic response. Total actual spending $8,705,432,497 ("a decrease of $52.3 million over the previous year," i.e. from an even larger FY2020-21 figure of $8,757,759,632). The same three core responsibilities already in place (health promotion and chronic disease prevention; infectious disease prevention and control; health security), but dominated by active emergency operations: 120+ million vaccine doses secured, 96+ million distributed; 2,473,943 border tests facilitated; Safe Voluntary Isolation Sites program at $181M funding 63 sites in 50 communities; a standardized Proof of Vaccination Credential built and funded for provinces/territories; 240+ million rapid tests distributed against a nearly $2B bulk-procurement commitment; wastewater surveillance at 60% national population coverage. Minister of Health: the Honourable Jean-Yves Duclos; Minister of Mental Health and Addictions: the Honourable Carolyn Bennett (5f36bf45a086).

FY2022-23 (drr-2023, ffd31d26f126) — first wind-down signals amid continued response. Actual spending $5,785,777,716, down from $8.7B. Report explicitly frames the year under the header "PHAC's Adaptive Response to COVID-19," language marking the first shift from pure emergency scaling toward managed transition. Border measures lifted October 1, 2022, ending the physical quarantine-officer presence at 35 priority points of entry and 17 Designated Quarantine Facilities (1,465 rooms, 14 cities). Safe Voluntary Isolation Sites funding nearly halved to $68M (64 sites, 51 communities, newly listing Ontario among served provinces). Vaccine donation program matured: 28.8 million surplus doses delivered to 36 recipient countries via COVAX and bilateral agreements. New: mpox outbreak response (wastewater testing, vaccine/therapeutic research, external science advisory panel); "PHAC Renewal," described as a Budget 2023 commitment "to support the Agency in laying the groundwork to establish an agile, resilient, and adaptive public health agency" — an early textual signal of the structural reset to come. 9-8-8 Suicide Crisis Helpline announced for a November 30, 2023 launch, CAMH to lead coordination. Minister of Health: the Honourable Mark Holland; Minister of Mental Health and Addictions: the Honourable Ya'ara Saks (ffd31d26f126).

FY2023-24 planning (dp-2024, d13c03e5ac2e) — the wind-down is explicitly forecast. Filed before the fiscal year closed, this plan already projects Infectious Disease Prevention and Control spending falling from $3,379,801,950 (2023-24) to $823,097,882 (2024-25) to $712,741,311 (2025-26), attributed to "the expiry of budgetary authorities for procurement of COVID-19 vaccines" and related sero-surveillance/surge-capacity authorities. Department-wide, the plan's own multi-year table shows total voted+statutory spending falling from $12,049,424,092 (2022-23, authorities basis — not directly comparable to drr-2023's $5.79B actual-spending figure) to a planned $4,216,773,473 (2023-24) and $1,444,349,469 (2024-25). President: Dr. Harpreet S. Kochhar (d13c03e5ac2e) — distinct from, and preceding, Heather Jeffrey.

FY2023-24 results (drr-2024, 2dde122d31ed) — wind-down realized. Actual spending $4,428,531,363 — close to, but above, the $4.2B the prior year's plan had projected. Three-year actual trend confirmed in-document: $8,705,432,497 (21-22) → $5,785,777,716 (22-23) → $4,428,531,363 (23-24), 4,191 FTEs. COVID-19 "progressively scaled down": border testing, travel/quarantine, and Safe Voluntary Isolation Sites demobilized (VISP administration continuing under OXARO, formerly Raymond Chabot Grant Thornton). New space-fillers consolidate: mpox federal vaccine reserve; an avian flu H5Nx expert panel (October 2023); measles re-emergence; opioids response (2023 record deaths, Canadian Drugs and Substances Strategy renewed October 2023, Harm Reduction Fund $7M/year); 9-8-8 helpline now live (November 2023); Antimicrobial Resistance 2023-27 Pan-Canadian Action Plan (June 2023); a Biomanufacturing and Life Sciences Strategy ($574M Canadian Biomanufacturing Response Fund/Biomedical Research Infrastructure Fund phase 2; Moderna mRNA facility construction completed, 100M doses/year capacity). Ministers (plural, reflecting a broader mental-health/sport portfolio split): Holland (Health), Saks (Mental Health/Addictions), Qualtrough (Sport). President: Heather Jeffrey (2dde122d31ed).

FY2024-25 planning (dp-2025, eeb62d7e5473). Total planned net spending for 2024-25 was $1,868,507,260 across a three-minister structure (Holland/Saks/Qualtrough, matching drr-2024) — notably higher than what actually materialized (drr-2025's $1,534,914,270 actual). Explanatory language cites gradual expiry of budgetary authorities for the Centre for Aging and Brain Health Innovation, mental-health-of-COVID-affected-populations funding, the three-digit suicide/distress line, and ParticipACTION, alongside gradual expiry of COVID-19 vaccine procurement authorities (partially offset by new influenza vaccine procurement funding for 2025-26/2026-27). No "Refocusing Government Spending" or other named austerity exercise appears anywhere in dp-2025's text — the RGS dollar figures first surface only in the results report for this same year (drr-2025), not in this forward-looking plan. President: Heather Jeffrey (eeb62d7e5473).

FY2024-25 results (drr-2025, 6da0f4be919d) — normalization plus explicit structural cuts. Actual spending $1,534,914,270, 4,035 FTEs — below dp-2025's own $1.87B plan for the same year. Same three core responsibilities, but for the first time an explicit numbered 13-item "key priorities" list appears at the results-report level, and the Departmental Results Framework (DRF) itself is flagged as "being rewritten to better align with PHAC's emerging core mandate," effective the 2026-27 Departmental Plan. COVID-19 is explicitly described as normalized: "shifting priorities away from the COVID-19 pandemic response" into routine multi-pathogen respiratory surveillance; the VISP program's mandated year-5 review is launched ahead of schedule (2025-26) with funding flagged for reduction. Refocusing Government Spending (Budget 2023) dollar figures appear explicitly for the first time in this document: $13,218,000 (2024-25) → $19,027,000 (2025-26) → $27,642,000 (2026-27 and after), against a 9% reduction in substantive positions and 16% decrease in executive roles in 2024-25. Escalating infectious-disease threats: measles cases in the first three months of 2025 exceeded any year since 1998 elimination; H5N1's first domestically acquired human case occurred in British Columbia, November 2024, with 870,000 GSK vaccine doses secured in response; mpox Emergency Response Committee activated, 200,000 doses donated internationally. New: National Suicide Prevention Action Plan (May 2024); Canada's Autism Strategy (September 2024); an Overdose Crisis Data Program built with Statistics Canada; a second mRNA manufacturing facility in Laval, QC (GMP-certified, production anticipated 2025); early AI adoption (NACI semi-automated literature screening, a WHO data pipeline, a Microsoft Copilot pilot). Leadership turnover: Minister Holland succeeded by Marjorie Michel; President Jeffrey succeeded by Nancy Hamzawi; the three-minister structure (Health/Mental Health/Sport) collapses to a single Minister of Health (6da0f4be919d).

FY2025-26 planning (dp-2026, abfdc35f4f96) — an interregnum year, transition visible but not yet named. Total planned spending $1,639,000,733 for 2025-26 (gross $1,639,950,733). President listed as "Nancy Hamzawi (interim)" — confirming the leadership transition disclosed in drr-2025 was mid-completion at the time this plan was filed. No numbered "key priorities" list yet (that structure first appears in dp-2027), and no "Refocusing Government Spending" or "Comprehensive Expenditure Review" language appears in this document either — dp-2026 sits in the gap between the RGS disclosure (drr-2025) and the CER disclosure (dp-2027). Planned FTEs are explicitly described as reflecting "an update to the methodology previously used and is based on workforce affordability," with FTEs "nearing a return to pre-pandemic staffing levels by 2026-27" — the clearest single-sentence articulation of the endemic-normalization endpoint anywhere in the series. Toronto Pearson International Airport named as one of the sites maintaining quarantine-officer presence (abfdc35f4f96).

FY2026-27 planning (dp-2027, 24cc5bc1ac28) — the reset is formalized. Total planned net spending $1,527,423,768 (matching the backgrounder's figure independently). Institutional head: Nancy Hamzawi, no longer marked "interim"; Minister: the Honourable Marjorie Michel. This is the first document in the series carrying an explicit numbered "Key priorities" list (7 items: mental/physical health promotion and suicide prevention; public-health-event preparedness/response; vaccination-rate increases and coverage-gap reduction; antimicrobial resistance; health security partnerships "to support a strong, sovereign Canada"; data/information management; science/innovation leadership countering mis/disinformation) — narrower and more consolidated than the ad hoc initiative list of the pandemic-era reports. A second, distinct austerity exercise appears for the first time: the "Comprehensive Expenditure Review," announced in Budget 2025 (textually separate from Budget 2023's Refocusing Government Spending, which drr-2025 had disclosed the prior year) — planned reductions of $12,700,000 (2026-27), $72,600,000 (2027-28), and $88,800,000 (2028-29), with an anticipated decrease of approximately 53 FTEs by 2028-29, delivered by "combining grants and contribution programs into larger funding streams" and "focusing spending on PHAC's core public health priorities." The plan states planned spending will keep falling through 2028-29, attributed to "the expiry of budgetary authorities in 2026–27 for a long-term approach for the renewal of the Agency – from Stabilization to Sustainability," the cancellation of "a contract for domestic vaccine development and manufacturing," and CER efficiencies (24cc5bc1ac28).

Priorities added, dropped, renamed

• Added — mental health/suicide prevention as a standing pillar: present in nascent form (Wellness Together Canada, Mental Health Promotion Innovation Fund) as early as drr-2022 (5f36bf45a086), consolidated into the 9-8-8 Suicide Crisis Helpline (announced drr-2023, ffd31d26f126; launched, named in drr-2024, 2dde122d31ed) and a National Suicide Prevention Action Plan (drr-2025, 6da0f4be919d) — by dp-2027 (24cc5bc1ac28) folded into key priority #1.
• Added — mpox response: absent from drr-2022; first appears drr-2023 (ffd31d26f126) as an active outbreak response, continues as a "federal vaccine reserve" through drr-2024 (2dde122d31ed) and an activated Emergency Response Committee with 200,000 donated doses in drr-2025 (6da0f4be919d).
• Added — H5N1/avian influenza as a named threat: first appears as an "expert panel" (October 2023) in drr-2024 (2dde122d31ed); escalates to Canada's first domestically acquired human case (BC, November 2024) with a dedicated vaccine-procurement response in drr-2025 (6da0f4be919d).
• Added — measles re-emergence: named in drr-2024 (2dde122d31ed) as "re-emergence"; by drr-2025 (6da0f4be919d) explicitly the worst case count "since elimination was achieved in 1998."
• Added — Antimicrobial Resistance as a distinct funded program: 2023-27 Pan-Canadian Action Plan named in drr-2024 (2dde122d31ed); carried into dp-2027's numbered key priorities (24cc5bc1ac28) — a rare case of a pandemic-era addition surviving into the post-reset priority list essentially unchanged.
• Added — domestic vaccine biomanufacturing: seeded as early as dp-2024 (d13c03e5ac2e, general "domestic biomanufacturing and life sciences" language), named with dollar figures and the Moderna facility in drr-2024 (2dde122d31ed), extended to a second Laval, QC mRNA facility in drr-2025 (6da0f4be919d) — then reportedly reversed: dp-2027 (24cc5bc1ac28) cites "the cancellation of a contract for domestic vaccine development and manufacturing" as one driver of planned spending declines, a contraction not further specified in this series (⚠️ still being checked which contract).
• Added — a numbered "key priorities" list as a reporting structure: absent from every Departmental Plan through dp-2026 (abfdc35f4f96); first appears as a 13-item list in drr-2025 (a results report, 6da0f4be919d) and then as a restructured 7-item list in dp-2027, the first Departmental Plan to carry one (24cc5bc1ac28).
• Dropped/wound down — direct COVID-19 emergency operations: border testing, quarantine officer deployment at scale, Safe Voluntary Isolation Sites, and Proof of Vaccination Fund support are all described as active in drr-2022 (5f36bf45a086), reduced in drr-2023 (ffd31d26f126, border measures lifted October 1, 2022), and described as demobilized in drr-2024 (2dde122d31ed); VISP's own year-5 review is moved earlier than scheduled with funding flagged for reduction in drr-2025 (6da0f4be919d).
• Dropped/collapsed — the three-minister portfolio structure: Holland (Health)/Saks (Mental Health and Addictions)/Qualtrough (Sport) stable across drr-2024 and dp-2025 (2dde122d31ed; eeb62d7e5473); collapsed to a single Minister of Health (Michel) by drr-2025 (6da0f4be919d) and continuing through dp-2027 (24cc5bc1ac28) — not explained in-text, but coinciding with the broader normalization narrative.
• Renamed/restructured — the austerity exercise itself: Budget 2023's "Refocusing Government Spending," first disclosed with dollar figures in drr-2025 (6da0f4be919d), is textually distinct from Budget 2025's "Comprehensive Expenditure Review," first disclosed in dp-2027 (24cc5bc1ac28) — two sequential, differently-named, differently-scoped federal restraint exercises rather than one continuous program.

Budget & mandate inflection points

• FY2021-22 actual spending peak: $8,705,432,497 (drr-2022, 5f36bf45a086), described as itself a decrease from an even higher FY2020-21 figure of $8,757,759,632 (5f36bf45a086; also independently visible in d13c03e5ac2e's retrospective table).
• October 1, 2022 — COVID-19 border measures lifted; quarantine-officer presence at 35 priority points of entry and 17 Designated Quarantine Facilities ends (ffd31d26f126).
• FY2023-24 actual spending: $4,428,531,363, down from $5,785,777,716 (22-23) and $8,705,432,497 (21-22) — a confirmed three-year, 49%-then-24%-then-further decline trajectory (2dde122d31ed).
• Budget 2023 "Refocusing Government Spending" — first disclosed with dollar figures in drr-2025: $13,218,000 (2024-25), $19,027,000 (2025-26), $27,642,000 (2026-27 and after); paired with a 9% cut to substantive positions and 16% cut to executive roles in 2024-25 (6da0f4be919d).
• FY2024-25 actual spending: $1,534,914,270, 4,035 FTEs — an 82% cumulative decline from the FY2021-22 peak in three fiscal years, and below dp-2025's own $1,868,507,260 plan for the same year (6da0f4be919d; eeb62d7e5473).
• DRF rewrite disclosed — drr-2025 states the Departmental Results Framework is "being rewritten to better align with PHAC's emerging core mandate," effective the 2026-27 Departmental Plan (6da0f4be919d); dp-2027 delivers the first numbered "Key priorities" list of the series, consistent with that disclosed rewrite, though dp-2027's own text does not use the phrase "Departmental Results Framework" to narrate the change explicitly (24cc5bc1ac28) — the rewrite's arrival is inferable from the structural change, not restated in so many words.
• Budget 2025 "Comprehensive Expenditure Review" — first disclosed in dp-2027: $12,700,000 (2026-27), $72,600,000 (2027-28), $88,800,000 (2028-29), ~53 FTE reduction by 2028-29, layered on top of and textually distinct from the earlier RGS reductions (24cc5bc1ac28).
• FY2026-27 planned net spending: $1,527,423,768 (dp-2027, 24cc5bc1ac28) — independently matching the backgrounder's cited figure; the plan states further declines are expected through 2028-29 due to "Stabilization to Sustainability" funding-authority expiry, cancellation of "a contract for domestic vaccine development and manufacturing," and CER efficiencies (24cc5bc1ac28).
• Leadership succession, ministers: Duclos/Bennett (drr-2022, 5f36bf45a086) → Holland/Saks/Qualtrough (drr-2023 through dp-2025, ffd31d26f126 through eeb62d7e5473) → Michel alone (drr-2025 onward, 6da0f4be919d through 24cc5bc1ac28).
• Leadership succession, President/institutional head: Dr. Harpreet S. Kochhar (dp-2024, d13c03e5ac2e) → Heather Jeffrey (drr-2024 through dp-2025, 2dde122d31ed; eeb62d7e5473) → Nancy Hamzawi, interim (dp-2026, abfdc35f4f96) → Nancy Hamzawi, confirmed (drr-2025 forward, 6da0f4be919d; 24cc5bc1ac28) — a four-name succession the pre-digest notes did not fully capture (it named only the Jeffrey→Hamzawi transition; this review's own read of dp-2024 recovers the earlier Kochhar presidency).

Ontario/Toronto relevance

Indirect throughout — PHAC is a federal agency headquartered in Ottawa (130 Colonnade Rd, per drr-2024, 2dde122d31ed) with no Toronto-based office or Toronto-specific program identified anywhere in this nine-document series. What the series does establish, plainly, without inflating boilerplate: (1) quarantine/border operations — Toronto Pearson International Airport is named as one of the sites maintaining PHAC quarantine-officer presence in dp-2026 (abfdc35f4f96) and dp-2027 lists Toronto among "Canada's four largest international airports" (with Montréal, Vancouver, Calgary) where PHAC maintains staff (24cc5bc1ac28), consistent with drr-2025's "quarantine officers at 4 major airports incl. Toronto" (6da0f4be919d); (2) research partnership — dp-2024 names PHAC's continued work with "Toronto Metropolitan University's National Institute" on an interactive COVID-19/respiratory-disease risk assessment tool (d13c03e5ac2e); (3) program delivery — dp-2025 names tobacco cessation supports (counselling, nicotine replacement therapy, peer support) available "in Ottawa and Toronto" (eeb62d7e5473); (4) community health partner, aggregate-level — drr-2024 names TAIBU Community Health Centre (Black Wellness Network) and CAMH's leadership of the 9-8-8 helpline, both Toronto-based institutions, in an institutional/programmatic capacity (2dde122d31ed); (5) provincial-level, not city-specific — drr-2023 names an ISAF-funded "Toronto and Region Conservation Authority" project in "the Greater Toronto Area, Ontario" on equitable access to healthy environments (ffd31d26f126), and Ontario is listed among provinces served by the Safe Voluntary Isolation Sites Program in drr-2023 (ffd31d26f126) and among provinces with pilot wastewater surveillance expansion in drr-2025 (6da0f4be919d, "U Windsor + wastewater expansion into Ontario," per pre-digest, not independently re-verified this review). None of this amounts to a Toronto-specific mandate; it is national infrastructure and national programming that happens to touch Toronto as Canada's largest metropolitan area and a major international airport.

Residuals & gaps

• Pre-digest reliance, spot-verified. drr-2024 and drr-2025 were covered by a salvaged pre-digest from orphaned reader agents, explicitly flagged as unverified. This session spot-verified 6 load-bearing claims directly against source text before relying on the pre-digest further: (1) FY2023-24 total actual spending $4,428,531,363 — confirmed exact (2dde122d31ed, line 1241/1318/1348); (2) the 3-year spending trend $8,705,432,497→$5,785,777,716→$4,428,531,363 — confirmed exact against drr-2024's own table (line 1239); (3) RGS dollar figures $13,218,000/$19,027,000/$27,642,000 — confirmed exact (6da0f4be919d, line 1630-1632); (4) the 9%/16% workforce-cut figures — confirmed exact, same paragraph (line 1468); (5) measles "more cases... than any year since 1998 elimination" — confirmed near-verbatim (line 1097, "more cases reported in the first three months of 2025 than in any previous year since elimination was achieved in 1998"); (6) H5N1 first domestic human case in BC, November 2024 — confirmed (line 1082). All six checks passed without correction. The pre-digest's characterization of a Dec 2022 Auditor General report finding "201M surplus doses" (attributed to VaccineConnect) was NOT independently re-verified this review — the AG report itself is not part of this org's 9-document archived set, and drr-2023's own text (independently read this review, ffd31d26f126) references a different named AG report ("Report 8—Pandemic Preparedness, Surveillance, and Border Measures") without stating the 201-million-dose figure; ⚠️ still being checked the specific AG report and figure the pre-digest had in mind, as it is not traceable to any document id in this archived set.
• Detector calls: no disagreement found, either direction. All 9 documents in _index.json are marked ok, and all 9 were confirmed to contain genuine, substantive report content on read (ranging from the 3,423-character AG audit summary to a 296,046-character Departmental Results Report). No stub-suspected or extract-failed documents in this org's set.
• Departmental Plans vs. Departmental Results Reports show materially different planned-vs-actual figures, worth flagging explicitly rather than treating as a single continuous number: dp-2024 planned FY2024-25 spending at $1,444,349,469 (d13c03e5ac2e); dp-2025 (filed later, same fiscal year in view for the following year) planned FY2024-25 at $1,868,507,260 (eeb62d7e5473); the actual outcome per drr-2025 was $1,534,914,270 (6da0f4be919d) — three different figures for spending touching the same fiscal year, reflecting normal in-year revision rather than any inconsistency in the record.
• Domestic vaccine manufacturing contract cancellation — dp-2027 cites "the cancellation of a contract for domestic vaccine development and manufacturing" as a driver of declining planned spending (24cc5bc1ac28) but does not name the contract or contractor; given the prominence of the Moderna and Laval mRNA facilities in drr-2024/drr-2025, ⚠️ still being checked whether this cancellation involves either of those named facilities or a separate, unnamed arrangement — this series cannot resolve which.
• ⚠️ Still being checked: the ~53-FTE Comprehensive Expenditure Review reduction (dp-2027, 24cc5bc1ac28) and its relationship, if any, to the separate FTE decline dp-2026 attributes to "a return to pre-pandemic staffing levels" (abfdc35f4f96) — the two documents describe overlapping-sounding but textually distinct FTE-reduction drivers, and this series does not disaggregate how much of the FY2026-27 to FY2028-29 FTE decline is CER-specific versus ordinary post-pandemic unwind.
• ⚠️ Still being checked: outcome/final scope of the Departmental Results Framework rewrite disclosed in drr-2025 (6da0f4be919d) — dp-2027 delivers a new numbered priorities structure consistent with a rewrite having occurred, but dp-2027's own text does not explicitly narrate "we rewrote the DRF" in so many words; the connection is inferred from structural change, not a direct textual confirmation.
• No archive_status=missing years and no era:pre-web-baseline flags apply to this series (registry flags column empty throughout, consistent with _index.json showing 9/9 ok).